Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

Delayed Data
As of May 27
 +0.79 / +0.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Biogen have a median target of 350.00, with a high estimate of 450.00 and a low estimate of 268.00. The median estimate represents a +23.77% increase from the last price of 282.79.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Biogen. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.51%
Growthannually 10.91%


Growthquarterly 1.77%
Growthannually 4.41%
Key to the earnings and sales forecast charts.